We are proud to announce that Matthew Zuckerman has joined the Stonehaven team.   We feel very fortunate to have attracted such a talented member to our alternative investment distribution team, and we are excited to continue to develop and enhance the overall depth and breadth of our distribution team.  Mr. Zuckerman will be covering institutional investors in the Midwest region of the United States.

Mr. Zuckerman is a Director on the hedge fund distribution team within Stonehaven, LLC.  Mr. Zuckerman manages institutional relationships and has significant experience within business development for institutional asset management firms and alternative investments.

Prior to joining Stonehaven, Mr. Zuckerman worked as an Associate at Goldman Sachs under the head partner of the firm’s G10 FX securities business on the management and strategy team.  Prior to Goldman Sachs, Mr. Zuckerman worked in various sales roles at SkyBridge Capital, and was instrumental in obtaining multiple institutional accounts.  Mr. Zuckerman began his career as a Finance and Acquisitions Analyst at a subsidiary of Trilantic Capital Partners, formerly Lehman Brothers Merchant Banking.

Mr. Zuckerman earned a B.A. from Georgetown University and an M.B.A. from the University of Oxford.  Mr. Zuckerman currently holds the Series 7 and 63 registrations FINRA.

About Stonehaven, LLC
Stonehaven is an industry leading global placement agent focused on hedge funds, private equity, real estate, venture capital, private placements, and long‐only strategies.  Stonehaven’s platform serves as a nexus between select investment opportunities and the institutional investment community with a talented capital raising team and robust infrastructure. The Firm’s dynamic structure fosters an ever‐ evolving stable of distinctive managers to match the demand across the diverse investor community. Founded in 2001 by CEO David Frank, the Firm is entirely management owned, giving it complete independence to continue pursuing its entrepreneurial approach while maintaining the highest ethical and regulatory standards.